@article{b91d43432499461bb8cd4180267a701e,
title = "Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis",
author = "Sigal, {Samuel H.} and Sanyal, {Arun J.} and Frederick, {R. Todd} and Weinberg, {Ethan M.} and Pappas, {S. Chris} and Khurram Jamil",
note = "Funding Information: Conflicts of interest The authors disclose the following: Samuel H. Sigal has received research support from Mallinckrodt Pharmaceuticals, and has received paid consulting advisor fees from Mallinckrodt Pharmaceuticals; Arun J. Sanyal has received paid consulting advisor fees from Mallinckrodt Pharmaceuticals, research grants from Mallinckrodt Pharmaceuticals; R. Todd Frederick has received paid consulting advisor fees from Mallinckrodt Pharmaceuticals, and research funding from Mallinckrodt Pharmaceuticals; Ethan M. Weinberg has received paid consulting advisor fees from Mallinckrodt Pharmaceuticals; S. Chris Pappas has received consulting advisor fees from Mallinckrodt Pharmaceuticals and Orphan Therapeutics, LLC, during the conduct of the study; and Khurram Jamil is an employee of Mallinckrodt Pharmaceuticals. ",
year = "2023",
doi = "10.1016/j.cgh.2023.02.015",
language = "English (US)",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
}
